百济神州,这家国内创新药领域的头部企业,今年迈入了成立的第15个年头。虽然它在抗肿瘤药物研发领域已经取得了不少积极成果,也有几款产品成功上市,但长期亏损的问题始终让人倍感压力。百济神州距离扭亏为盈,到底还有多远?01致力创新药2010年10月,癌症科学家王晓东和连续创业者欧雷强联手创立了百济神州。这是一家专注于抗肿瘤创新药,覆盖First-in-class首创新药、Me-better优化改良型药物...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.